论文部分内容阅读
目的探讨布地奈德联合特布他林雾化吸入治疗哮喘患儿的临床疗效。方法选取2012年1月到2015年10月茂名市电白区妇幼保健院收治的1800例哮喘患儿作为研究对象,依据治疗方式不同将其分为照组(单独雾化吸入布地奈德)和联合组(布地奈德联合特布他林雾化吸入治疗),各900例。比较两组患儿临床症状改善情况、肺功能变化情况及临床疗效。结果联合组患儿咳嗽、喘憋、呼吸困难、哮鸣音消失时间均明显短于对照组,差异均有统计学意义(均P<0.05);治疗后,联合组患儿的第1秒钟用力呼气容积占预计值百分比(FEV1%)和最大呼气流量占预计值百分比(PEF%)均明显高于对照组,差异均有统计学意义(均P<0.05);联合组患儿治疗的总有效率明显高于对照组,差异有统计学意义(P<0.05)。结论布地奈德联合特布他林雾化吸入治疗哮喘患儿临床疗效明显,可明显改善患儿临床症状及肺功能。
Objective To investigate the clinical efficacy of budesonide combined with terbutaline in the treatment of children with asthma. Methods A total of 1800 asthmatic children admitted to Dianbai Maternal and Child Health Care Hospital of Maoming City from January 2012 to October 2015 were selected as study subjects and divided into two groups according to the different treatment methods: control group (inhalation of budesonide alone) and The combination group (budesonide combined with terbutaline nebulization treatment), each 900 cases. The clinical symptom improvement, lung function changes and clinical curative effect were compared between the two groups. Results The cough, wheezing, dyspnea and wheezing disappeared in the combined group were significantly shorter than those in the control group (all P <0.05). After the treatment, the first second of the combined group (FEV1%) and maximum expiratory flow (PEF%) were significantly higher than the control group, the differences were statistically significant (all P <0.05); combined treatment of children with treatment The total effective rate was significantly higher than the control group, the difference was statistically significant (P <0.05). Conclusion Budesonide combined with Terbutaline nebulization treatment of children with asthma clinical significant effect, can significantly improve the clinical symptoms and lung function in children.